In a geographic area with low ultraviolet light index, the frequency of epithelial neoplasia seen in excised pterygium specimens was higher than expected, according to a Canadian study. The rate was 2.33%.Of 215 pterygium specimens received at the Henr…
SHP607 reduces BPD, IVH among premature infants in phase 2 trial
SHP607, a recombinant human version of insulin-like growth factor 1 and IGF binding protein-3 from Shire, effectively reduced development of severe bronchopulmonary dysplasia and severe intraventricular hemorrhage among extremely preterm infants, accor…
New keratoconus classification guides customization of intracorneal ring segment implantation
OVIEDO, Spain — A new keratoconus classification oriented to the implantation of intracorneal ring segments was presented at the second European Meeting of Young Ophthalmologists. “Our classification is aimed at using Ferrara rings and originates from Ferrara’s morphological classification. It is based on ectasia location and uses asphericity, topographic astigmatic patterns and the relationship between topographic, comatic and refractive axis as parameters,” Luis Fernández-Vega, MD, said.
VIDEO: Speaker relates advantages of UV cross-linking for treatment of keratoconus
OVIEDO, Spain — At the second European Meeting of Young Ophthalmologists, Nina Jacobsen, MD, PhD, discusses the advantages of UV cross-linking in lieu of intrastromal corneal ring segments for the treatment of keratoconus.
Global Corneal Ulcers Pipeline Report 2016 Featuring Amakem NV, Digna Biotech, & Lee’s Pharmaceutical – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Corneal Ulcers – Pipeline Review, H1 2016” report to their offering. This report provides comprehensive information on the therapeutic development for Corneal Ulcers, comp…
Global Retinitis Pigmentosa Pipeline Report 2016 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Retinitis Pigmentosa (Retinitis) – Pipeline Review, H1 2016” report to their offering. This report provides comprehensive information on the therapeutic development for Re…